Prediagnostic expressions in health records predict mortality in Parkinson's disease: A proof-of-concept study

被引:3
|
作者
Kuusimaki, Tomi [1 ,2 ]
Sainio, Jani [3 ,4 ]
Kurki, Samu [3 ,4 ]
Vahlberg, Tero [5 ]
Kaasinen, Valtteri [1 ,2 ]
机构
[1] Univ Turku, Clin Neurosci, Turku, Finland
[2] Turku Univ Hosp, Neuroctr, Hameentie 11,POB 52, FIN-20521 Turku, Finland
[3] Univ Turku, Auria Biobank, Turku, Finland
[4] Turku Univ Hosp, Turku, Finland
[5] Univ Turku, Dept Biostat, Turku, Finland
关键词
Parkinson 's disease; Prodromal; Data mining; Electronical health records; Mortality; Prognosis; MOTOR; RISK; ASSOCIATION; DEPRESSION; SURVIVAL; FEATURES; CRITERIA;
D O I
10.1016/j.parkreldis.2021.12.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The relationship of prodromal markers of PD with PD mortality is unclear. Electronic health records (EHRs) provide a large source of raw data that could be useful in the identification of novel relevant prognostic factors in PD. We aimed to provide a proof of concept for automated data mining and pattern recognition of EHRs of PD patients and to study associations between prodromal markers and PD mortality. Methods: Data from EHRs of PD patients (n = 2522) were collected from the Turku University Hospital database between 2006 and 2016. The data contained >27 million words/numbers and >750000 unique expressions. The 5000 most common words were identified in three-year time period before PD diagnosis. Cox regression was used to investigate the association of expressions with the 5-year survival of PD patients. Results: During the five-year period after PD diagnosis, 839 patients died (33.3%). If expressions associated with psychosis/hallucinations were identified within 3 years before the diagnosis, worse survival was observed (hazard ratio = 1.71, 95%CI = 1.46-1.99, p < 0.001). Similar effects were observed for words associated with cognition (1.23, 1.05-1.43, p = 0.009), constipation (1.34, 1.15-1.56, p = 0.0002) and pain (1.34, 1.12-1.60, p = 0.001). Conclusions: Automated mining of EHRs can predict relevant clinical outcomes in PD. The approach can identify factors that have previously been associated with survival and detect novel associations, as observed in the link between poor survival and prediagnostic pain. The significance of early pain in PD prognosis should be the focus of future studies with alternate methods.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [11] Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study
    Li, Danni
    Huang, Fangying
    Zhao, Yingchun
    Villata, Peter W.
    Griffin, Timothy J.
    Zhang, Lin
    Li, Ling
    Yu, Fang
    CLINICAL PROTEOMICS, 2018, 15
  • [12] Recruitment rate, feasibility and safety of power training in individuals with Parkinson's disease: a proof-of-concept study
    Lima, Lidiane O.
    Rodrigues-de-Paula, Fatima
    BRAZILIAN JOURNAL OF PHYSICAL THERAPY, 2013, 17 (01) : 49 - 56
  • [13] Linking cohort-based data with electronic health records: a proof-of-concept methodological study in Hong Kong
    Gao, Le
    Leung, Miriam T. Y.
    Li, Xue
    Chui, Celine S. L.
    Wong, Rosa S. M.
    Yeung, Shiu Lun Au
    Chan, Edward W. W.
    Chan, Adrienne Y. L.
    Chan, Esther W.
    Wong, Wilfred H. S.
    Lee, Tatia M. C.
    Rao, Nirmala
    Wing, Yun Kwok
    Lum, Terry Y. S.
    Leung, Gabriel M.
    Ip, Patrick
    Wong, Ian C. K.
    BMJ OPEN, 2021, 11 (06):
  • [14] In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study
    Zygogianni, Ourania
    Antoniou, Nasia
    Kalomoiri, Maria
    Kouroupi, Georgia
    Taoufik, Era
    Matsas, Rebecca
    NEUROCHEMICAL RESEARCH, 2019, 44 (06) : 1475 - 1493
  • [15] Mortality of People with Parkinson's Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration
    Okunoye, Olaitan
    Horsfall, Laura
    Marston, Louise
    Walters, Kate
    Schrag, Anette
    MOVEMENT DISORDERS, 2021, 36 (12) : 2811 - 2820
  • [16] Neuroprotective effects of Tradescantia spathacea tea bioactives in Parkinson ' s disease: In vivo proof-of-concept
    Lopes, Lorenna E. S.
    Barroso, Sheilla da Silva
    Caldas, Joanny K. M.
    Vasconcelos, Paulo R.
    Canuto, Kirley M.
    Dariva, Claudio
    Santos, Klebson S.
    Severino, Patricia
    Cardoso, Juliana C.
    Souto, Eliana B.
    Gomes, Margarete Z.
    JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2024, 14 (04): : 435 - 445
  • [17] Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial
    Videnovic, Aleksandar
    Amara, Amy W.
    Comella, Cynthia
    Schweitzer, Paula K.
    Emsellem, Helene
    Liu, Kris
    Sterkel, Amanda L.
    Gottwald, Mildred D.
    Steinerman, Joshua R.
    Jochelson, Philip
    Zomorodi, Katie
    Hauser, Robert A.
    MOVEMENT DISORDERS, 2021, 36 (10) : 2408 - 2412
  • [18] Proteomic Profile of Saliva in Parkinson's Disease Patients: A Proof of Concept Study
    Figura, Monika
    Sitkiewicz, Ewa
    Swiderska, Bianka
    Milanowski, Lukasz
    Szlufik, Stanislaw
    Koziorowski, Dariusz
    Friedman, Andrzej
    BRAIN SCIENCES, 2021, 11 (05)
  • [19] Twenty-Three-Year Mortality in Parkinson's Disease: A Population-Based Prospective Study (NEDICES)
    Benito-Rodriguez, Carla Maria
    Bermejo-Pareja, Felix
    Berbel, Angel
    Lapena-Motilva, Jose
    Benito-Leon, Julian
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [20] Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
    Schrag, Anette
    Horsfall, Laura
    Walters, Kate
    Noyce, Alastair
    Petersen, Irene
    LANCET NEUROLOGY, 2015, 14 (01) : 57 - 64